Pathophysiology of contrast medium-induced nephropathy

Kidney International

Volumn 68, Issue 1, 2005, Pages 14-22

  Persson, Pontus B ^a   Hansell, Peter ^b   Liss, Per ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b NONE

Author keywords

Contrast media; Nephropathy; Osmolality; Viscosity

Indexed keywords

ADENOSINE; CONTRAST MEDIUM; DIATRIZOATE; DIMER; ENDOTHELIN; IODIXANOL; IOHEXOL; IOMEPROL; IOPAMIDOL; IOPROMIDE; IOTROLAN; IOXAGLIC ACID; MONOMER; REACTIVE OXYGEN METABOLITE;

AUTOCRINE EFFECT; BLOOD VISCOSITY; DIMERIZATION; FLOW KINETICS; HEALTH SURVEY; HUMAN; HYPOXIA; KIDNEY BLOOD FLOW; KIDNEY DISEASE; NEPHROTOXICITY; OSMOLALITY; OSMOLARITY; PARACRINE SIGNALING; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; ACUTE KIDNEY FAILURE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; PATHOPHYSIOLOGY; UROLOGIC EXAMINATION;

CONTRAST MEDIA; DIAGNOSTIC TECHNIQUES, UROLOGICAL; HUMANS; KIDNEY FAILURE, ACUTE; OSMOLAR CONCENTRATION; RHEOLOGY;

EID: 24944514021     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00377.x     Document Type: Article

References (92)

1. ASPELIN P, AUBRY P, FRANSSON SG, et al: Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491-499, 2003
2. SOLOMON R, WERNER C, MANN D, et al: Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416-1420, 1994
3. BARRETT BJ, PARFREY PS, VAVASOUR HM, et al: Contrast nephropathy in patients with impaired renal function: High versus low osmolar media. Kidney Int 41:1274-1279, 1992
4. RUDNICK MR, GOLDFARB S, WEXLER L, et al: Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The lohexol Cooperative Study. Kidney Int 47:254-261, 1995
5. TALIERCIO CP, VLIETSTRA RE, ILSTRUP DM, et al: A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography. J Am Coll Cardiol 17:384-390, 1991
6. MANSKE CL, SPRAFKA JM, STRONY JT, WANG Y: Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89:615-620, 1990
7. WAYBILL MM, WAYBILL PN: Contrast media-induced nephrotoxicity: Identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 12:3-9, 2001
8. LEVY EM, VISCOLI CM, HORWITZ RI: The effect of acute renal failure on mortality. A cohort analysis. JAMA 275:1489-1494, 1996
9. THOMSEN HS, MORCOS SK: Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 76:513-518, 2003
10. LISS P, NYGREN A, ERIKSON U, ULFENDAHL HR: Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney Int 53:698-702, 1998
11. DAWSON P: Cardiovascular effects of contrast agents. Am J Cardiol 64:2E-9E, 1989
12. SCHIANTARELLI P, PERONI F, TIRONE P, ROSATI G: Effects of iodinated contrast media on erythrocytes. I. Effects of canine erythrocytes on morphology. Invest Radiol 8:199-204, 1973
13. LISS P, NYGREN A, OLSSON U, et al: Effects of contrast media and mannitol on renal medullary blood flow and red cell aggregation in the rat kidney. Kidney Int 49:1268-1275, 1996
14. NYGREN A, HELLBERG O, HANSELL P: Red-cell trapping in the rat renal microcirculation induced by low-osmolar contrast media and mannitol. Invest Radiol 28:1033-1038, 1993
15. UEDA J, NYGREN A, HANSELL P, ERIKSON U: Influence of contrast media on single nephron glomerular filtration rate in rat kidney. A comparison between diatrizoate, iohexol, ioxaglate, and iotrolan. Acta Radiol 33:596-599, 1992
16. UEDA J, NYGREN A, HANSELL P, ULFENDAHL HR: Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney. Acta Radiol 34:83-87, 1993
17. SCHNERMANN J, PLOTH DW, HERMLE M: Activation of tubuloglomerular feedback by chloride transport. Pflugers Arch 362:229-240, 1976
18. BRIGGS JP, SCHNERMANN J, WRIGHT FS: Failure of tubule fluid osmolarity to affect feedback regulation of glomerular filtration. Am J Physiol 239:F427-F432, 1980
19. LEYSSAC PP, HOLSTEIN-RATHLOU NH, SKOTT O: Renal blood flow, early distal sodium, and plasma renin concentrations during osmotic diuresis. Am J Physiol Regul Integr Comp Physiol 279:R1268-R1276, 2000
20. BREZIS M, ROSEN S: Hypoxia of the renal medulla - Its implications for disease. N Engl J Med 332:647-655, 1995
21. BREZIS M, ROSEN S, SILVA P, EPSTEIN FH: Selective vulnerability of the medullary thick ascending limb to anoxia in the isolated perfused rat kidney. J Clin Invest 73:182-190, 1984
22. HEYMAN SN, BREZIS M, REUBINOFF CA, et al: Acute renal failure with selective medullary injury in the rat. J Clin Invest 82:401-412, 1988
23. LANCELOT E, IDEE JM, COUTURIER V, et al: Influence of the viscosity of iodixanol on medullary and cortical blood flow in the rat kidney: A potential cause of nephrotoxicity. J Appl Toxicol 19:341-346, 1999
24. HEYMAN SN, REICHMAN J, BREZIS M: Pathophysiology of radiocontrast nephropathy: A role for medullary hypoxia. Invest Radiol 34:685-691, 1999
25. ARAKAWA K, SUZUKI H, NAITOH M, et al: Role of adenosine in the renal responses to contrast medium. Kidney Int 49:1199-1206, 1996
26. AGMON Y, PELEG H, GREENFELD Z, et al: Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 94:1069-1075, 1994
27. HEYMAN SN, GOLDFARB M, CARMELI F, et al: Effect of radiocontrast agents on intrarenal nitric oxide (NO) and NO synthase activity. Exp Nephrol 6:557-562, 1998
28. NEAGLEY SR, VOUGHT MB, WEIDNER WA, ZWILLICH CW: Transient oxygen desaturation following radiographic contrast medium administration. Arch Intern Med 146:1094-1097, 1986
29. KIM SJ, SALEM MR, JOSEPH NJ, et al: Contrast media adversely affect oxyhemoglobin dissociation. Anesth Analg 71:73-76, 1990
30. LISS P, NYGREN A, ULFENDAHL HR, ERIKSON U: Effect of furosemide or mannitol before injection of a non-ionic contrast medium on intrarenal oxygen tension. Adv Exp Med Biol 471:353-359, 1999
31. HEYMAN SN, BREZIS M, GREENFELD Z, ROSEN S: Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat. Am J Kidney Dis 14:377-385, 1989
32. HARDIEK K, KATHOLI RE, RAMKUMAR V, DEITRICK C: Proximal tubule cell response to radiographic contrast media. Am J Physiol Renal Physiol 280:F61-F70, 2001
33. ANDERSEN KJ, CHRISTENSEN EI, VIK H: Effects of iodinated x-ray contrast media on renal epithelial cells in culture. Invest Radiol 29:955-962, 1994
34. HIZOH I, STRATER J, SCHICK CS, et al: Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: Role of hypertonicity. Nephrol Dial Transplant 13:911-918, 1998
35. BEERI R, SYMON Z, BREZIS M, et al: Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int 47:1806-1810, 1995
36. HALLER C, SCHICK CS, ZORN M, KUBLER W: Cytotoxicity of radiocontrast agents on polarized renal epithelial cell monolayers. Cardiovasc Res 33:655-665, 1997
37. SCHNACKENBERG CG: Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol 282:R335-R342, 2002
38. JANLE-SWAIN E: Animal models of diabetic nephropathy, in Handbook of Animal Models of Renal Failure, edited by Ash S, Thornhill J, Boca Baton, CRC Press, 1985
39. ISHII N, PATEL KP, LANE PH, et al: Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol 12:1630-1639, 2001
40. OHISHI K, CARMINES PK: Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J Am Soc Nephrol 5:1559-1566, 1995
41. PALM F, CEDERBERG J, HANSELL P, et al: Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 46:1153-1160, 2003
42. BAKRIS GL, LASS N, GABER AO, et al: Radiocontrast medium-induced declines in renal function: A role for oxygen free radicals. Am J Physiol 258:F115-F120, 1990
43. KATHOLI RE, WOODS WT, JR., TAYLOR GJ, et al: Oxygen free radicals and contrast nephropathy. Am J Kidney Dis 32:64-71, 1998
44. TEPEL M, VAN DER GIET M, SCHWARZFELD C, et al: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180-184, 2000
45. DIAZ-SANDOVAL LJ, KOSOWSKY BD, LOSORDO DW: Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 89:356-358, 2002
46. BRIGUORI C, MANGANELLI F, SCARPATO P, et al: Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 40:298-303, 2002
47. SHYU KG, CHENG JJ, KUAN P: Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 40:1383-1388, 2002
48. ALLAQABAND S, TUMULURI R, MALIK AM, et al: Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 57:279-283, 2002
49. KAY J, CHOW WH, CHAN TM, et al: Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: A randomized controlled trial. JAMA 289:553-558, 2003
50. WALKER PD, BROKERING KL, THEOBALD JC: Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: A review. Pharmacotherapy 23:1617-1626, 2003
51. BIRCK R, KRZOSSOK S, MARKOWETZ F, et al: Acetylcysteine for prevention of contrast nephropathy: Meta-analysis. Lancet 362:598-603, 2003
52. ALONSO A, LAU J, JABER BL, et al: Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: A meta-analysis of randomized, controlled trials. Am J Kidney Dis 43:1-9, 2004
53. DURHAM JD, CAPUTO C, DOKKO J, et al: A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 62:2202-2207, 2002
54. KSHIRSAGAR AV, POOLE C, MOTTL A, et al: N-acetylcysteine for the prevention of radiocontrast induced nephropathy: A meta-analysis of prospective controlled trials. J Am Soc Nephrol 15:761-769, 2004
55. WEIHPRECHT H, LORENZ JN, BRIGGS JP, SCHNERMANN J: Vasomotor effects of purinergic agonists in isolated rabbit afferent arterioles. Am J Physiol 263:F1026-F1033, 1992
56. WEAVER DR, REPPERT SM: Adenosine receptor gene expression in rat kidney. Am J Physiol 263:F991-F995, 1992
57. SPIELMAN WS, AREND LJ: Adenosine receptors and signaling in the kidney. Hypertension 17:117-130, 1991
58. OLIVERA A, LAMAS S, RODRIGUEZ-PUYOL D, LOPEZ-NOVOA JM: Adenosine induces mesangial cell contraction by an A1-type receptor. Kidney Int 35:1300-1305, 1989
59. OSSWALD H, HERMES HH, NABAKOWSKI G: Role of adenosine in signal transmission of tubuloglomerular feedback. Kidney Int (Suppl 12):S136-S142, 1982
60. SUN D, SAMUELSON LC, YANG T, et al: Mediation of tubuloglomerular feedback by adenosine: Evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci USA 98:9983-9988, 2001
61. BROWN R, OLLERSTAM A, JOHANSSON B, et al: Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol 281:R1362-R1367, 2001
62. PERSSON PB: Tubuloglomerular feedback in adenosine A1 receptor-deficient mice. Am J Physiol Regul Integr Camp Physiol 281:R1361, 2001
63. OLDROYD SD, FANG L, HAYLOR JL, et al: Effects of adenosine receptor antagonists on the responses to contrast media in the isolated rat kidney. Clin Sci (Lond) 98:303-311, 2000
64. KATHOLI RE, TAYLOR GJ, MCCANN WP, et al: Nephrotoxicity from contrast media: Attenuation with theophylline. Radiology 195:17-22, 1995
65. PFLUEGER A, LARSON TS, NATH KA, et al: Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus. Mayo Clin Proc 75:1275-1283, 2000
66. LISS P, CARLSSON PO, PALM F, HANSELL P: Adenosine A(1) receptors in contrast media-induced renal dysfunction in the normal rat. Eur Radiol 14:1297-1302, 2004
67. DINOUR D, AGMON Y, BREZIS M: Adenosine: An emerging role in the control of renal medullary oxygenation? Exp Nephrol 1:152-157, 1993
68. SEO B, OEMAR BS, SIEBENMANN R, et al: Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89:1203-1208, 1994
69. BAGNIS C, IDEE JM, DUBOIS M, et al: Role of endothelium-derived nitric oxide-endothelin balance in contrast medium-induced acute renal vasoconstriction in dogs. Acad Radiol 4:343-348, 1997
70. CLARK BA, KIM D, EPSTEIN FH: Endothelin and atrial natriuretic peptide levels following radiocontrast exposure in humans. Am J Kidney Dis 30:82-86, 1997
71. HEYMAN SN, CLARK BA, KAISER N, et al: Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 3:58-65, 1992
72. OLDROYD SD, MORCOS SK: Endothelin: What does the radiologist need to know? Br J Radiol 73:1246-1251, 2000
73. FUUSAKI K, KUBO M, MASUDA K, et al: Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function. Clin Exp Nephrol 7:279-283, 2003
74. WANG A, HOLCSLAW T, BASHORE TM, et al: Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 57:1675-1680, 2000
75. FREED MI, WILSON DE, THOMPSON KA, et al: Pharmacokinetics and pharmacodynamics of SB 209670, an endothelin receptor antagonist: Effects on the regulation of renal vascular tone. Clin Pharmacol Ther 65:473-482, 1999
76. WEBER C, SCHMITT R, BIRNBOECK H, et al: Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects. Clin Pharmacol Ther 60:124-137, 1996
77. HAYLOR JL, MORCOS SK: An oral ET(A)-selective endothelin receptor antagonist for contrast nephropathy? Nephrol Dial Transplant 16:1336-1337, 2001
78. LISS P, CARLSSON PO, NYGREN A, et al: Et-A receptor antagonist BQ123 prevents radiocontrast media-induced renal medullary hypoxia. Acta Radiol 44:111-117, 2003
79. MORCOS SK, THOMSEN HS, WEBB JA: Contrast-media-induced nephrotoxicity: A consensus report. Contrast Media Safety Committee. European Society of Urogenital Radiology (ESUR). Eur Radiol 9:1602-1613, 1999
80. KATZBERG RW: Urography into the 21st century: New contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology 204:297-312, 1997
81. MORCOS SK: Prevention of contrast media nephrotoxicity - The story so far. Clin Radiol 59:381-389, 2004
82. MURPHY SW, BARRETT BJ, PARFREY PS: Contrast nephropathy. J Am Soc Nephrol 11:177-182, 2000
83. TRIVEDI HS, MOORE H, NASR S, et al: A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93:C29-C34, 2003
84. LORENZ JN, NIEMAN M, SABO J, et al: Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load. J Clin Invest 112:1244-1254, 2003
85. GAMI AS, GAROVIC VD: Contrast nephropathy after coronary angiography. Mayo Clin Proc 79:211-219, 2004
86. NAFZ B, BERGER K, ROSLER C, PERSSON PB: Kinins modulate the sodium-dependent autoregulation of renal medullary blood flow. Cardiovasc Res 40:573-579, 1998
87. FRANCHINI KG, COWLEY AW, JR.: Sensitivity of the renal medullary circulation to plasma vasopressin. Am J Physiol 271:R647-R653, 1996
88. FRANCHINI KG, COWLEY AW, JR.: Renal cortical and medullary blood flow responses during water restriction: Role of vasopressin. Am J Physiol 270:R1257-R1264, 1996
89. BARRETT BJ: Contrast nephrotoxicity. J Am Soc Nephrol 5:125-137, 1994
90. BARRETT BJ, CARLISLE EJ: Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171-178, 1993
91. 2) digital subtraction angiography: 26-year experience at the University of Florida. Eur Radiol 8:391-402, 1998
92. THOMSEN HS, MORCOS SK: Radiographic contrast media. BJU Int 86 (Suppl 1):1-10, 2000